Search

13C-metabolic flux analysis for mevalonate-producing strain of Escherichia coli

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 고무
      2. 플라스틱
    • 바이오정밀화학
      1. 용매
      2. 화학제품
    • 화장품용 기능성소재
      1. 계면활성제⁄증점제
    • 의료용 화학소재
      1. 식품첨가제
논문

13C-metabolic flux analysis for mevalonate-producing strain of Escherichia coli

학술지

Journal of bioscience and bioengineering

저자명

Wada, K.; Toya, Y.; Banno, S.; Yoshikawa, K.; Matsuda, F.; Shimizu, H.

초록

Mevalonate (MVA) is used to produce various useful products such as drugs, cosmetics and food additives. An MVA-producing strain of Escherichia coli (engineered) was constructed by introducing mvaES genes from Enterococcus faecalis. The engineered strain produced 1.84 mmol/gDCW/h yielding 22% (C-mol/C-mol) of MVA from glucose in the aerobic exponential growth phase. The mass balance analysis revealed that the MVA yield of the engineered strain was close to the upper limit at the biomass yield. Since MVA is synthesized from acetyl-CoA using NADPH as a cofactor, the production of MVA affects central metabolism in terms of carbon utilization and NADPH requirements. The reason for this highly efficient MVA production was investigated based on <SUP>13</SUP>C-metabolic flux analysis. The estimated flux distributions revealed that the fluxes of acetate formation and the TCA cycle in the engineered strain were lower than those in the control strain. Although the oxidative pentose phosphate pathway is considered as the NADPH generating pathway in E. coli, no difference of the flux was observed between the control and engineered strains. The production/consumption balance of NADPH suggested that additional requirement of NADPH for MVA synthesis was obtained from the transhydrogenase reaction in the engineered strain. Comparison between the measured flux distribution and the ideal values for MVA production proposes a strategy for further engineering to improve the MVA production in E. coli.

발행연도

2017

발행기관

Society for Bioscience and Bioengineering, Japan ; Distributed outside Japan by Elsevier Science

ISSN

1389-1723

ISSN

1347-4421

123

2

페이지

pp.177-182

주제어

13C-metabolic flux analysis; Mevalonate; Escherichia coli; Flux distribution; Redox balance; Flux balance analysis

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

2건의 후보군 물질이 있습니다.

1 2023-12-11
2 2023-12-11

논문; 2017-02-01

Export

About

Search

Trend